Computational Biology Market Is Estimated to Rise to US $2.93 Billion by the End of 2018
Computational biology is also referred to as bioinformatics; it makes use of algorithms based on biological data to establish relations between different biological systems. By creating sophisticated modeling and simulation models for pharmacodynamics and pharmacokinetics, several recent drug discovery and development projects have made use of computational biology with successful results. This has consequently impelled the adoption of this technique among several companies in the pharmaceuticals industry worldwide. The greatest advantage of computational biology is that it helps reduce the...
View full press release